Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 29 Jan 2024
Without increasing toxicity, OS, PFS, and cancer-specific survival all increased.
Read Full NewsThe World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning that the highly addictive products were being...
Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.
The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.
1.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
2.
The Effect of Common Steroids on Cancer Treatments.
3.
Study sheds light on challenges for women of color after breast cancer surgery
4.
In women with extremely dense breasts, elevated MRI enhancement can help identify cancer risk.
5.
Research discovery halts childhood brain tumor before it forms
1.
The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia
2.
Polyposis Syndrome: Causes, Symptoms, and Treatment Options
3.
Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients
4.
IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity
5.
Unveiling the Hidden Benefits of Lymphedema Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
3.
Navigating the Complexities of Ph Negative ALL - Part XIII
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge